Literature DB >> 15776274

In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum.

Oystein Bruserud1, Karl Johan Tronstad, Rolf Berge.   

Abstract

PURPOSE: Experimental in vitro models including well-characterised cell lines can be used to identify possible new therapeutic targets for the treatment of osteosarcoma. Culture media including inactivated serum is often recommended for in vitro culture of osteosarcoma cells, but the serum component then represents a nonstandardised parameter including a wide range of unidentified mediators. To improve the standardisation we have investigated whether serum-free culture media can be used in experimental in vitro studies of osteosarcoma cell lines.
METHODS: The seven osteosarcoma cell lines Cal72, SJSA-1, Saos-2, SK-ES-1, U2OS, 143.98.2, and KHOS-32IH were cultured in vitro in various serum-free media and media supplemented with 10% heat-inactivated fetal calf serum (FCS).
RESULTS: Although proliferation often was relatively low in serum-free media (X-vivo 10, X-vivo 15, X-vivo 20, Stem Span SFEM), some cell lines (Cal72, KHOS-32IH, Saos-2) showed proliferation comparable with the recommended FCS-containing media even when using serum-free conditions. The optimal serum-free medium then varied between cell lines. We also compared 6 different FCS-containing media (including Stem Span with 10% FCS) and the optimal FCS-containing medium varied between cell lines. However, all cell lines proliferated well in Stem Span with FCS, and this medium was regarded as optimal for four of the lines. FCS could not be replaced by fatty acids or low density lipoprotein when testing the Stem Span medium. The release of a wide range of soluble mediators showed only minor differences when using serum-free and FCS-containing media (including Stem Span with and without FCS), and serum-free Stem Span could also be used for in vitro studies of mitogen-stimulated T cell activation in the presence of accessory osteosarcoma cells. The use of Stem Span with 10% FCS allowed the release of a wide range of chemokines by osteosarcoma cell lines (Cal72, SJSA-1), and the chemokine release profile was very similar to the fibroblast lines Hs27 and HFL1.
CONCLUSIONS: Serum-free culture media can be used for in vitro studies of several osteosarcoma cell lines, but the optimal medium varies between cell lines and thus depends on: (i) the cell lines to be investigated/compared; (ii) the functional characteristic that is evaluated (proliferation, cytokine release); and (iii) whether coculture experiments are included.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15776274     DOI: 10.1007/s00432-004-0650-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

2.  T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation.

Authors:  O Bruserud; E Ulvestad; S Berentsen; J Bergheim; I Nesthus
Journal:  Scand J Immunol       Date:  1998-01       Impact factor: 3.487

3.  Induction of peroxisomal beta-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues.

Authors:  O Spydevold; J Bremer
Journal:  Biochim Biophys Acta       Date:  1989-05-15

4.  Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).

Authors:  N Rochet; J Dubousset; C Mazeau; E Zanghellini; M F Farges; H S de Novion; A Chompret; B Delpech; N Cattan; M Frenay; J Gioanni
Journal:  Int J Cancer       Date:  1999-07-19       Impact factor: 7.396

5.  In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media.

Authors:  O Bruserud; S Frostad; B Foss
Journal:  J Hematother       Date:  1999-02

Review 6.  New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.

Authors:  O Bruserud; B T Gjertsen
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

Review 7.  Metabolic effects of thia fatty acids.

Authors:  Rolf K Berge; Jon Skorve; Karl Johan Tronstad; Kjetil Berge; Oddrun Anita Gudbrandsen; Hans Grav
Journal:  Curr Opin Lipidol       Date:  2002-06       Impact factor: 4.776

8.  Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.

Authors:  O Bruserud ; E Ulvestad
Journal:  Cell Immunol       Date:  2000-11-25       Impact factor: 4.868

9.  Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression.

Authors:  Hans J Grav; Karl J Tronstad; Oddrun A Gudbrandsen; Kjetil Berge; Kari E Fladmark; Tom C Martinsen; Helge Waldum; Hege Wergedahl; Rolf K Berge
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

10.  Bone cancers.

Authors:  H D Dorfman; B Czerniak
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

View more
  11 in total

1.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

2.  Sclerostin expression in skeletal sarcomas.

Authors:  Jia Shen; Carolyn A Meyers; Swati Shrestha; Arun Singh; Greg LaChaud; Vi Nguyen; Greg Asatrian; Noah Federman; Nicholas Bernthal; Fritz C Eilber; Sarah M Dry; Kang Ting; Chia Soo; Aaron W James
Journal:  Hum Pathol       Date:  2016-08-03       Impact factor: 3.466

3.  Comparison of three culture media for the establishment of melanoma cell lines.

Authors:  M C Pandolfino; S Saïagh; A C Knol; B Dréno
Journal:  Cytotechnology       Date:  2010-08-21       Impact factor: 2.058

4.  Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells.

Authors:  Tsuyoshi Shimo; Shinsuke Matsumura; Soichiro Ibaragi; Sachiko Isowa; Koji Kishimoto; Hiroshi Mese; Akiyoshi Nishiyama; Akira Sasaki
Journal:  J Cell Commun Signal       Date:  2007-10-04       Impact factor: 5.782

5.  Influence of various medium environment to in vitro human T cell culture.

Authors:  Hao Xu; Na Wang; Wenyue Cao; Liang Huang; Jianfeng Zhou; Lingshuang Sheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-07-12       Impact factor: 2.416

6.  Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production.

Authors:  Aline Bozec; Latifa Bakiri; Maria Jimenez; Thorsten Schinke; Michael Amling; Erwin F Wagner
Journal:  J Cell Biol       Date:  2010-09-13       Impact factor: 10.539

7.  Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.

Authors:  Elise Aasebø; Annette K Brenner; Maria Hernandez-Valladares; Even Birkeland; Frode S Berven; Frode Selheim; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

8.  Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells.

Authors:  Håkon Reikvam; Ina Nepstad; Øystein Bruserud; Kimberley Joanne Hatfield
Journal:  Oncotarget       Date:  2013-06

9.  Fluoride promotes viability and differentiation of osteoblast-like Saos-2 cells via BMP/Smads signaling pathway.

Authors:  Liangliang Huo; Kangkang Liu; Junrui Pei; Yanmei Yang; Yan Ye; Yang Liu; Jing Sun; Hepeng Han; Weimin Xu; Yanhui Gao
Journal:  Biol Trace Elem Res       Date:  2013-08-07       Impact factor: 3.738

10.  In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells.

Authors:  Hilde Kvestad; Lasse Evensen; James B Lorens; Oystein Bruserud; Kimberley J Hatfield
Journal:  Leuk Res Treatment       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.